Vincent Wong

1: In 2025, look out for a new section in @JHepatology:  "Breakthroughs Beyond the Journal". Editorial-style analyses of pivotal liver research 2: My comment on work from @Cell_Metabolism showing that MI drives #MASH. The interaction between these two diseases works BOTH ways 👇

@EASLnews @AleksanderKrag @FrancqueSven @apdpdiabetes @brennap9 @MajaThiele @schattenbergJ @AlkhouriNaim @marurinella @FattyLiverA @fprusso73 @ajay_duseja @ArunJSanyalVCU @HannesHagstrom @rabataller @PoseElisa @LuisAntonioDiaz @BrettEFortuneMD @AlinaAllenMD @IsraelsenMads @tomhemmingk @NoureddinMD @melina_manolas @mromerogomez @DrJavierCrespo @FDA @JSGracia @juanpabloarab @Dr_Ampuero @pericas_jm @AASLDtweets @AmerGastroAssn @lucavalenti75 @SagiZelber @EuropeLiver @scottisaacsmd @ebtapper @EASOobesity @WorldObesity @JCabezasGlez @DrJLCalleja @LiverPatients @LiverAim @salvatore_piano Prof @SagiZelber presenting "Food inequity and insecurity and MASLD: burden, challenges, and interventions." We need to up our collaboration game and breakdown silos: nature.com/articles/s4157… @NatRevGastroHep #SLDsummit

@TerryYip12 @JHepatology @wonglaihung @CUHKMedicine @CUHKGI Congratulations, @TerryYip12 and friends!

New study at @JHepatology unveils how two-step clinical care pathway for #MASLD predicts #MALOs. Many thanks to all collaborators! Explore our latest #VCTE-Prognosis Study: shorturl.at/wBeSM! @VWSWong @wonglaihung @CUHKMedicine @CUHKGI

What’s the best way to implement the 2-step clinical care pathway for evaluating MASLD? Is it as effective as VCTE for all patients? Check out this paper in J Hep: authors.elsevier.com/sd/article/S01…. Congrats to @TerryYip12 and the VCTE-Prognosis Study Team! 🎉 #MASLD #ClinicalResearch

A new blood-based biomarker for #MASH has been confirmed in diverse US and Chinese populations. Amazing collaboration among @CUHKMedicine, @UCSDHealth, and Wenzhou Medical University! Read more in Cell Metabolism: #undfig1" target="_blank" rel="nofollow noopener">sciencedirect.com/science/articl…

Call for abstracts for the MetALD Conference in San Diego Nov 14 at Westin Gaslamp Quarter- A star-studded panel of faculty from over 25 institutions worldwide - @VWSWong @MarcoArreseMD @QAnstee @DrHuangDQ @juanpabloarab @mcharltonmd metaldconference.org/agenda #livertwitter

This is probably the first MetALD Conference ever. Thank you, @DrLoomba, for hosting this in San Diego! metaldconference.org

Great new #GUTVideo by Su et al on "Lactococcus lactis HkyuLL 10 suppresses colorectal tumourigenesis and restores gut microbiota through its generated alpha-mannosidase" via bit.ly/3AVAIOA Paper via: bit.ly/4fRTVRh @CUHKofficial @CUHKMedicine #ColorectalCancer

👋#LiverTwitter What is your diagnosis❓ 41yo woman: dark urine, scleral icterus, fatigue, shortness of breath, RUQ pain ➡️AST 364U/L ➡️ALT 393U/L ➡️ALP 155U/L ➡️Bilirubin 9.2 mg/dl ➡️Progestin-only OCP 7wks prior History of photosensitivity Case🔗bit.ly/3XvVpsg

Achieving SVR doesn’t mean you’re free from liver cancer. The new AI-Safe-C score can identify patients at residual cancer risk. Stay informed! Congratulations, Huapeng! #Hepatology #LiverCancer #AI #fig1" target="_blank" rel="nofollow noopener">journal-of-hepatology.eu/article/S0168-…

🆕Article in press❕ Porto-sinusoidal vascular liver disorder with portal hypertension: Natural History and Long-Term Outcome Read it here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Excited to share our new review: "Food inequity and insecurity and MASLD: burden, challenges, and interventions" nature.com/articles/s4157…, led by @SagiZelber, with @pericas_jm and more! @NatRevGastroHep #LiverTwitter

REVIEW Epidemiology, screening, and co-management of type 2 diabetes mellitus and metabolic dysfunction–associated steatotic liver disease Qi et al. ​​#LiverX @DrLoomba tinyurl.com/297a6kt6

Possibly the most satisfying achievement for physician-scientists: When your proposal stands the test of time & defines clinical practice. 👉 @BavenoCoop for cACLD after HCV-cure ➡️ @EASLnews Position Paper 🔗 bit.ly/3Va2uh2 @JHepatology 🫶 @GeorgSemmler @SaSi_Lens

"Prevalence and prognosis of patients with MASLD-related cirrhosis after an ICU hospitalization in France: A single-centre prospective study" available open access at bit.ly/46hBW2f #livertwitter

Important paper 🚨 👇🏻!!!

Published open access at bit.ly/3S9Emdz "Faecal biomarkers for diagnosis and prediction of disease course in treatment-naïve patients with IBD" #GIwitter

Van Gogh-like 2 is essential for the architectural patterning of the mammalian biliary tree Full text here👉journal-of-hepatology.eu/article/S0168-… #LiverTwitter

Patients with covert HE has a higher probability of developing overt HE than patients with other causes of neurocognitive impairment (NI). Read the full paper by Sultanik et al 'open access' at bit.ly/45XWiNP #GItwitter